New eye drop aims to beat artificial tears for dry eye relief
Symptom relief
Not yet recruiting
This study tests a new eye drop called BRM421 against standard artificial tears in 99 adults with dry eye disease. The goal is to see if BRM421 is safe and better at reducing eye damage and discomfort. Participants will use the drops for 6 weeks, and doctors will measure changes …
Phase: PHASE2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC